ATHXQ — Athersys Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $9.77m
- $5.33m
Athersys Inc reports results for the quarter ended in June - Earnings Summary
Brief: Athersys Posts Quarterly Loss Per Share Of $0.10
Athersys Inc expected to post a loss of 10 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Gannett, FireEye, Novavax Inc
U.S. STOCKS ON THE MOVE-Kaixin Auto, Dicerna Pharma, Yelp
U.S. STOCKS ON THE MOVE-Yelp, GoPro, Switch
Athersys Inc jumps as respiratory disease treatment shows promise
Brief: Athersys Partner Healios K.K. Announces Positive Topline Results Of Multistem For Acute Respiratory Distress Syndrome In The One-Bridge Study
Athersys Inc reports results for the quarter ended in March - Earnings Summary
Brief: Athersys Reports First Quarter 2021 Results
Brief: Athersys Announces Financial Results For Fourth Quarter And Full Year 2020
Brief: Athersys Announces Cooperation Agreement With HEALIOS K.K.
Brief: Athersys Says Gil Van Bokkelen To Step Down As Chairman, CEO
Brief: UTHealth In Houston And Athersys Announce Commencement Of Patient Enrollment In A Phase 2 Trial Evaluating Multistem Cell Therapy In Trauma
Brief: Healios K.K. Says Hardy Ts Kagimoto, CEO Of Healios Sent Letter To Other Members Of Athersys Board
Brief: Hardy Ts Kagimoto says On Nov 21, Filed A Complaint For Inspection Of Books And Records In Court Of Chancery Of Delaware Against Athersys
Brief: Hardy Ts Kagimoto Says Objects To The Process That Led To The Athersys Board’S Recent Appointment Of Three New Directors
Brief: Athersys Announces Three Appointments To Board Of Directors
Brief: Hardy Ts Kagimoto Believes Athersys Need To Improve Its Operational Execution